ABPI-150

N/A

Report date: 2022/06/07 09:23:04
NME

Base Information

Drug NameABPI-150
Drug Alias NameABP-150ABPI-150
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesApollo Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApollo Pharma
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A